Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hemostemix Inc (TSE:HEM)
TSXV:HEM
Hemostemix (HEM) Stock Price & Analysis
11 Followers
HEM Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.05 - C$0.18
Previous CloseC$0.05
Volume111.00K
Average Volume (3M)38.85K
Market Cap
C$4.36M
Enterprise ValueC$8.27M
Total Cash (Recent Filing)C$377.59K
Total Debt (Recent Filing)C$4.29M
Price to Earnings (P/E)-1.2
Beta0.52
Next Earnings
Apr 30, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding87,122,318
10 Day Avg. Volume24,324
30 Day Avg. Volume38,848
Standard Deviation0.83
R-Squared0.00046
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)-0.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-16.50
P/FCF Ratio22.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hemostemix News
HEM FAQ
What was Hemostemix Inc’s price range in the past 12 months?
Hemostemix Inc lowest stock price was C$0.05 and its highest was C$0.17 in the past 12 months.
What is Hemostemix Inc’s market cap?
Currently, no data Available
When is Hemostemix Inc’s upcoming earnings report date?
Hemostemix Inc’s upcoming earnings report date is Apr 30, 2024 which is tomorrow.
How were Hemostemix Inc’s earnings last quarter?
Hemostemix Inc released its earnings results on Nov 29, 2023. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is Hemostemix Inc overvalued?
According to Wall Street analysts Hemostemix Inc’s price is currently Overvalued.
Does Hemostemix Inc pay dividends?
Hemostemix Inc does not currently pay dividends.
What is Hemostemix Inc’s EPS estimate?
Hemostemix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hemostemix Inc have?
Hemostemix Inc has 87,122,314 shares outstanding.
What happened to Hemostemix Inc’s price movement after its last earnings report?
Hemostemix Inc reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hemostemix Inc?
Currently, no hedge funds are holding shares in TSE:HEM
---
Hemostemix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Hemostemix Inc
Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.
---
Technical Analysis
---